PHARMA CLINIC BRS LTDActive

Company number 08064580Private limited companyIncorporated 2012

Key figures

£139,562-23.3%
Net assets 2024/25
+32.4%
Average annual growth 2019/20–2024/25
0100 k200 k300 k2019/202020/212021/222022/232023/242024/25

Like most small UK companies, PHARMA CLINIC BRS LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0250 k500 k750 k2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand182,915119,29683,63578,070115,727
Total assets649,457515,839437,841397,098394,003
Total liabilities—————
Net assets / total equity132,601196,050224,981182,007139,562
Average number of employees1415161212

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: PHARMA CLINIC BRS LTD

Company

PHARMA CLINIC BRS LTD is a private limited company registered with Companies House under company number 08064580. It was incorporated on 10 May 2012. Its status is active. The registered office is in London (E11). Its nature of business (SIC 2007) is dispensing chemist in specialised stores (47730), other retail sale of new goods in specialised stores (not commercial art galleries and opticians) (47789).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Oct 2025); the company files small company accounts (filleted). Net assets were £139,562, down 23.3% on the previous year. Cash at bank and in hand was £115,727. The company had an average of 12 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

3 persons with significant control are registered. 3 of 4 registered charges are outstanding.

Filing deadlines

The next accounts are due by 31 Jul 2027. The next confirmation statement is due by 4 Jul 2027.